Ramucirumab Medication Profile

Summary or Key Points

Ramucirumab is a targeted therapy used in the treatment of various types of cancers including gastric cancer, non-small cell lung cancer, colorectal cancer, and hepatocellular carcinoma. It works by inhibiting angiogenesis, or blood vessel growth, which in turn restricts cancer growth. This medication is prescribed by healthcare providers and is available in a specified dose and frequency. Consult your healthcare provider, potentially via telemedicine, before making any changes to your dosage.

Names of Medication

US Brand Name: Cyramza (Ramucirumab)

The term ‘generic name’ refers to the official medical name of the active ingredient in the medication. In this case, Ramucirumab is the generic name, and it’s given in parenthesis after the brand name.

Pharmacologic Category

Ramucirumab is an angiogenesis inhibitor and belongs to the class of medications known as monoclonal antibodies. Other medications in this category include Bevacizumab (Avastin) and Aflibercept (Eylea).

Dosing

It is essential to remember that the dosing of Ramucirumab can vary based on individual patient needs and the specific type of cancer being treated. Always consult your healthcare provider before adjusting your dose. Our telemedicine providers are available to assist with this.

• Gastric Cancer: 8 mg/kg every two weeks until disease progression or unacceptable toxicity.
• Non-Small Cell Lung Cancer: 10 mg/kg every three weeks until disease progression or unacceptable toxicity.
• Colorectal Cancer: 8 mg/kg every two weeks until disease progression or unacceptable toxicity.
• Hepatocellular Carcinoma: 8 mg/kg every two weeks until disease progression or unacceptable toxicity.

Dosage Forms and Strengths

Ramucirumab (Cyramza) is available in single-dose vials containing 100 mg/10 mL or 500 mg/50 mL of Ramucirumab.

Administration Instructions

Ramucirumab is given as an infusion into a vein (intravenous, or IV). It is usually administered under the supervision of a healthcare professional in a clinical setting.

Adverse Reactions and Side Effects

All medications can cause side effects. Here are the potential side effects and adverse reactions for Ramucirumab:

• Common (may affect up to 1 in 10 people): High blood pressure, diarrhea, headache.
• Uncommon (may affect up to 1 in 100 people): Nosebleeds, stomach ache, rash, infusion-related reactions.
• Rare (may affect up to 1 in 1,000 people): Severe bleeding, holes in the gut wall (perforation), serious skin reactions.

Should you experience any side effects or have any concerns, contact your healthcare provider immediately. Our telemedicine service can provide quick access to medical advice.

Contraindications

In medicine, a contraindication refers to a specific situation in which a drug or procedure should not be used because it may be harmful to the patient. Here are the contraindications for Ramucirumab:

• Severe bleeding or gastrointestinal perforation: Patients who have had severe bleeding or a hole in the gut wall (perforation) should not take Ramucirumab, as it could exacerbate these conditions.
• Allergy to Ramucirumab: People who have previously had an allergic reaction to Ramucirumab or any of its components should not take this medication.

Drug to Drug Interactions

Currently, there are no known significant drug interactions with Ramucirumab. However, this does not mean that interactions do not exist, so always inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, vitamins, and herbal products.

Ramucirumab in Pregnancy

It is not recommended to take Ramucirumab during pregnancy. Animal studies have shown that it can harm the fetus. If you are pregnant or planning to become pregnant, discuss this with your healthcare provider before starting this medication.

Ramucirumab while Breastfeeding

It is not known whether Ramucirumab is excreted in breast milk. Therefore, it is recommended to avoid breastfeeding while taking this medication. Always consult with your healthcare provider for advice related to your specific situation.

Estimated Cost of Medication

The estimated cost of a 30-day supply of Ramucirumab, using a GoodRx coupon and without insurance, is approximately $10,000. However, costs can vary widely based on location and pharmacy.

Possible Alternatives

While Ramucirumab has proven beneficial for many patients, it’s crucial to discuss any potential alternative treatments with your healthcare provider. Here are some possibilities:

• Gastric Cancer: Other treatments may include surgery, radiation therapy, other chemotherapy medications, and palliative care. Lifestyle changes, such as diet modifications, can also support overall health.
• Non-Small Cell Lung Cancer: Alternative treatments might include surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy. Smoking cessation is a critical lifestyle change for this condition.
• Colorectal Cancer: Surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapy could be alternatives. Maintaining a high-fiber diet and regular exercise might also help.
• Hepatocellular Carcinoma: Other treatments may involve surgery, liver transplant, ablation therapy, radiation therapy, and chemotherapy. Avoiding alcohol and maintaining a healthy weight are beneficial lifestyle changes.

Recent Updates on Ramucirumab Research

Recent studies have been exploring the use of Ramucirumab in combination with other treatments to enhance its effectiveness. For instance, a study published in 2023 showed that Ramucirumab, when used with immunotherapy drugs, showed promise in treating advanced hepatocellular carcinoma. As research continues, more applications and benefits of this medication may be discovered.

Brief Legal Disclaimer: This article is for informational purposes only and not intended as medical advice. Always consult a healthcare professional for diagnosis and treatment. Reliance on the information provided here is at your own risk.